Demand for Hepatitis E Diagnostic Tests in UK

Demand for Hepatitis E Diagnostic Tests in UK Size and Share Forecast Outlook 2026 to 2036

Demand for hepatitis E d iagnostic tests in UK is projected to grow from USD 3.8 million in 2026 to USD 6.2 million by 2036, at a CAGR of 5.0%. ELISA HEV IgM Tests will dominate with a 47.8% market share, while hospitals will lead the end use segment with a 41.2% share.

Demand for Hepatitis E Diagnostic Tests in UK
  • FACT12654MR
  • 15 Dec 2025
  • Healthcare
  • 170 Pages
  • 6 Tables
  • 21 Figures

Table of Content

  1. Executive Summary
    • UK Market Outlook
    • Demand to side Trends
    • Supply to side Trends
    • Technology Roadmap Analysis
    • Analysis and Recommendations
  2. Market Overview
    • Market Coverage / Taxonomy
    • Market Definition / Scope / Limitations
  3. Market Background
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunity
      • Trends
    • Scenario Forecast
      • Demand in Optimistic Scenario
      • Demand in Likely Scenario
      • Demand in Conservative Scenario
    • Opportunity Map Analysis
    • Product Life Cycle Analysis
    • Supply Chain Analysis
    • Investment Feasibility Matrix
    • Value Chain Analysis
    • PESTLE and Porter’s Analysis
    • Regulatory Landscape
    • Regional Parent Market Outlook
    • Production and Consumption Statistics
    • Import and Export Statistics
  4. UK Market Analysis 2021 to 2025 and Forecast, 2026 to 2036
    • Historical Market Size Value (USD Million) Analysis, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Projections, 2026 to 2036
      • Y to o to Y Growth Trend Analysis
      • Absolute $ Opportunity Analysis
  5. UK Market Pricing Analysis 2021 to 2025 and Forecast 2026 to 2036
  6. UK Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Product Type
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Product Type, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Product Type, 2026 to 2036
      • ELISA HEV IgM Tests
      • ELISA HEV IgG Tests
      • Rapid Diagnostic Tests
      • PCR Tests
      • Others
    • Y to o to Y Growth Trend Analysis By Product Type, 2021 to 2025
    • Absolute $ Opportunity Analysis By Product Type, 2026 to 2036
  7. UK Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By End Use
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By End Use, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By End Use, 2026 to 2036
      • Hospitals
      • Diagnostics Laboratories
      • Blood Banks
      • Others
    • Y to o to Y Growth Trend Analysis By End Use, 2021 to 2025
    • Absolute $ Opportunity Analysis By End Use, 2026 to 2036
  8. UK Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Region
    • Introduction
    • Historical Market Size Value (USD Million) Analysis By Region, 2021 to 2025
    • Current Market Size Value (USD Million) Analysis and Forecast By Region, 2026 to 2036
      • UK
    • Market Attractiveness Analysis By Region
  9. UK Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
      • By Product Type
      • By End Use
    • Market Attractiveness Analysis
      • By Country
      • By Product Type
      • By End Use
    • Key Takeaways
  10. Market Structure Analysis
    • Competition Dashboard
    • Competition Benchmarking
    • Market Share Analysis of Top Players
      • By Regional
      • By Product Type
      • By End Use
  11. Competition Analysis
    • Competition Deep Dive
      • F. Hoffmann-La Roche Ltd
        • Overview
        • Product Portfolio
        • Profitability by Market Segments (Product/Age /Sales Channel/Region)
        • Sales Footprint
        • Strategy Overview
          • Marketing Strategy
          • Product Strategy
          • Channel Strategy
      • Wantai BioPharm
      • PerkinElmer Inc.
      • Altona Diagnostics
      • MP Biomedicals LLP
      • Dia.Pro Diagnostic Bioprobes srl
      • ELITechGroup
      • Primerdesign Ltd
      • Mikrogen GmbH
      • Fortress Diagnostics
  12. Assumptions & Acronyms Used
  13. Research Methodology

List Of Table

  • Table 1: UK Market Value (USD Million) Forecast by Region, 2021 to 2036
  • Table 2: UK Market Value (USD Million) Forecast by Product Type, 2021 to 2036
  • Table 3: UK Market Value (USD Million) Forecast by End Use, 2021 to 2036
  • Table 4: UK Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 5: UK Market Value (USD Million) Forecast by Product Type, 2021 to 2036
  • Table 6: UK Market Value (USD Million) Forecast by End Use, 2021 to 2036

List Of Figures

  • Figure 1: UK Market Pricing Analysis
  • Figure 2: UK Market Value (USD Million) Forecast 2021 to 2036
  • Figure 3: UK Market Value Share and BPS Analysis by Product Type, 2026 and 2036
  • Figure 4: UK Market Y to o to Y Growth Comparison by Product Type, 2026 to 2036
  • Figure 5: UK Market Attractiveness Analysis by Product Type
  • Figure 6: UK Market Value Share and BPS Analysis by End Use, 2026 and 2036
  • Figure 7: UK Market Y to o to Y Growth Comparison by End Use, 2026 to 2036
  • Figure 8: UK Market Attractiveness Analysis by End Use
  • Figure 9: UK Market Value (USD Million) Share and BPS Analysis by Region, 2026 and 2036
  • Figure 10: UK Market Y to o to Y Growth Comparison by Region, 2026 to 2036
  • Figure 11: UK Market Attractiveness Analysis by Region
  • Figure 12: UK Market Incremental Dollar Opportunity, 2026 to 2036
  • Figure 13: UK Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 14: UK Market Value Share and BPS Analysis by Product Type, 2026 and 2036
  • Figure 15: UK Market Y to o to Y Growth Comparison by Product Type, 2026 to 2036
  • Figure 16: UK Market Attractiveness Analysis by Product Type
  • Figure 17: UK Market Value Share and BPS Analysis by End Use, 2026 and 2036
  • Figure 18: UK Market Y to o to Y Growth Comparison by End Use, 2026 to 2036
  • Figure 19: UK Market Attractiveness Analysis by End Use
  • Figure 20: UK Market - Tier Structure Analysis
  • Figure 21: UK Market - Company Share Analysis

Demand for Hepatitis E Diagnostic Tests in UK